SAM 학술관계분석서비스

논문영향력 요약
주제	cholesterol lactobacillus obesity probiotics
848	0	0.0%

논문영향력
주제	주제별 논문수	주제별 피인용횟수	주제별 논문영향력
주제어	cholesterol	154	0	0.0%
lactobacillus	87	0	0.0%
obesity	339	0	0.0%
probiotics	268	0	0.0%
계		848	0	0.0%
* 다른 주제어 보유 논문에서 피인용된 횟수	0

von Wright, A., and L. Axelsson. 2000. Lactic acid bacteria: an introduction, In: Lahtinne, S.,Salminen, S., von Wright, A., and A. Ouwehand., eds., Lactic Acid Bacteria: Microbiological andFunctional Aspects. London: CRC Press. pp. 1-16.

von Gravenitz, A., and C. Bucher. 1983. Accuracy of the KOH and vancomycin tests in determiningthe gram reaction of non-enterobacterial rods. J. Clin. Microbiol. 16:983-985.

du Toit, M., Franz, C. M., Dicks, L. M., Schillinger, U., Haberer, P., Warlies, B., Ahrensc, F., and W. H. Holzapfela. 1998. Characterisation and selection of probiotic lactobacilli for a preliminary minipigfeeding trial and their effect on serum cholesterol levels, faeces pH and faeces moisture content. Int. J. Food Microbiol. 40:93-104.

de Roos, N. M., Schouten, G., and M. B. Katan. 1999. Yoghurt enriched with Lactobacillusacidophilus does not lower blood lipids in healthy men and women with normal to borderline highserum cholesterol levels. Eur. J. Clin. Nutr. 53:277-280.

Zeyda, M., and T. M. Stulnig. 2007. Adipose tissue macrophages. Immunol. Lett. 112:61-67.

Younes, H., Coudray, C., Bellanger, J. Demigne, C., Rayssiguier, Y., and C. Remesy. 2001. Effects oftwo fermentable carbohydrates (inulin and resistant starch) and their combination on calcium andmagnesium balance inrats. Br. J. Nutr. 86:479-485.

Yoo, S. R., Kim, Y. J., Park, D. Y., Jung, U. J., Jeon, S. M., Ahn, Y. T., Huh, C. S., McGregor, R., andM. S. Choi. 2013. Probiotics L. plantarum and L. curvatus in combination alter hepatic lipidmetabolism and suppress diet-induced obesity. Obesity (Silver Spring). 21:2571-2578.

Yin, Y. N., Yu, Q. F., Fu, N., Liu, X. W., and F. G. Lu. 2010. Effects of four bifidobacteria on obesityin high-fat diet induced rats. World J. Gastroenterol. 16:3394-3401.

Xu, J., Mahowald, M. A., Ley, R. E., Lozupone, C. A., Hamady, M., Martens, E. C., Henrissat, B.,Coutinho, P. M., Minx, P., Latreille, P., Cordum, H., Van Brunt, A., Kim, K., Fulton, R. S., Fulton, L. A., Clifton, S. W., Wilson, R. K., Knight, R. D., and J. I. Gordon. 2007. Evolution of symbioticbacteria in the distal human intestine. PLoS Biol. 19:e156.

Xie, N., Cui, Y., Yin, Y. N., Zhao, X., Yang, J. W., Wang, Z. G., Fu, N., Tang, Y., Wang, X. H., Liu, X.W., Wang, C. L., and F. G. Lu. 2011. Effects of two Lactobacillus strains on lipid metabolism andintestinal microflora in rats fed a high-cholesterol diet. BMC Complement. Altern. Med. 11:53.

Xiao, J. Z., Kondo, S., Takahashi, N., Miyaji, K., Oshida, K., Hiramatsu, A., Iwatsuki, K., Kokubo, S.,and A. Hosono. 2003. Effects of milk products fermented by Bifidobacterium longum on blood lipidsin rats and healthy adult male volunteers. J. Dairy Sci. 86:2452-2461.

Watanabe, T., Sato, K., Itoh, F., Noguchi, Y., Fujimoto, K., Koyama, T., and M. Shichiri. 2013.Emerging roles for vasoactive peptides in diagnostic and therapeutic strategies against atheroscleroticcardiovascular diseases. Curr. Protein Pept. Sci. 14:472-480.

Wang, J., Zhang, H., Chen, X., Chen, Y., Menghebilige, and Q. Bao. 2012. Selection of potentialprobiotic lactobacilli for cholesterol-lowering properties and their effect on cholesterol metabolism inrats fed a high-lipid diet. J. Dairy Sci. 95:1645-1654.

Walker, W. A. 2000. Role of nutrients and bacterial colonization in the development of intestinal hostdefense. J. Pediatr. Gastroenterol. Nutr. 30:S2-S7.

Walker, D. K., and S. E. Gilliland. 1993. Relationship among bile tolerance, bile salt deconjugation,and assimilation of cholesterol by Lactobacillus acidophilus. J. dairy sci. 76:956-961.

Waldram, A., Holmes, E., Wang, Y., Rantalainen, M., Wilson, I. D., Tuohy, K. M., McCartney, A. L.,Gibson, G. R., and J. K. Nicholson. 2009. Top-down systems biology modelling of host metabotypemicrobiomeassociations in obese rodents. J. Proteome Res. 8:2361-2375.

Vanderhoof, J. A. 2000. Probiotics and intestinal inflammatory disorders in infants and children. J.Pediatr. Gastroenterol. Nutr. 30:S34-S38.

Usman, and A. Hosono. 1999. Bile tolerance, taurocholate deconjugation, and binding of cholesterolby Lactobacillus gasseri strains. J. Dairy Sci. 82:243-248.

Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., and J. I. Gordon. 2006.An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 444:1027-1031.

Turnbaugh, P. J., Ley, R. E., Hamady, M., Fraser-Liggett, C. M., Knight, R., and J. I. Gordon. 2007.The human microbiome project. Nature. 449:804-810.

Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L.,Jones, W. J., Roe, B. A., Affourtit, J. P., Egholm, M., Henrissat, B., Heath, A. C., Knight, R., and J. I.Gordon. 2009. Acore gut microbiome in obese and lean twins. Nature. 457:480-484.

Turnbaugh, P. J., Backhed, F., Fulton, L., and J. I. Gordon. 2008. Diet induced obesity is linked tomarked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 17:213-223.

Tomioka, H., Sato, K., and H. Saito. 1992. The protective activity of immune stimulants againstListeria monocytogenes infection in mice. J. Med. Microbiol. 36:112-116.

Terahara, M., Nishide, S., and T. Kaneko. 2000. Preventive effect of Lactobacillus delbrueckii subsp.bulgaricus on the oxidation of LDL. Biosci. Biotechnol. Biochem. 64:1868-1873.

Taranto, M. P., Medici, M., Perdigon, G., Ruiz Holgado, A. P., and G. F. Valdez. 1998. Evidence forhypocholesterolemic effect of Lactobacillus reuteri in hypercholesterolemic mice. J. Dairy Sci.81:2336-2340.

Tanida, M., Shen, J., Maeda, K., Horii, Y., Yamano, T., Fukushima, Y., and K. Nagai. 2008. High-fatdiet-induced obesity is attenuated by probiotic strain Lactobacillus paracasei ST11 (NCC2461) in rats.Obes. Res. Clin. Pract. 2:159-169.

Takemura, N., Okubo, T., and K. Sonoyama. 2010. Lactobacillus plantarum strain No. 14 reducesadipocyte size in mice fed high-fat diet. Exp. Biol. Med. 235:849-856.

Tahri, K., Grill, J. P., and F. Schneider. 1997. Involvement of trihydroxyconjugated bile salts incholesterol assimilation by bifidobacteria. Curr. Microbiol. 34:79-84.

Tahri, K., Grill, J. P., and F. Schneider. 1996. Bifidobacteria strain behavior toward cholesterol:coprecipitation with bile salts and assimilation. Curr. Microbiol. 33:187-193.

Sultana, K., Godward, G., Reynolds, N., Arumugaswamy, R., Peiris, P., and K. Kailasapathy. 2000.Encapsulation of probiotic bacteria with alginate-starch and evaluation of survival in simulatedgastrointestinal conditions and in yoghurt. Int. J. Food Microbiol. 62:47-55.

Succi, M., Tremonte, P., Reale, A., Sorrentino, E., Grazia, L., Pacifico, S., and R. Coppola. 2005. Bilesalt and acid tolerance of Lactobacillus rhamnosus strains isolated from Parmigiano Reggiano cheese.FEMS Microbiol. Lett. 244:129-137.

Stiles, M. E., and W. H. Holzapfel. 1997. Lactic acid bacteria of foods and their current taxonomy. Int.J. Food Microbiol. 36:1-29.

St-Onge, M. P., Farnworth, E. R., and P. J. Jones. 2000. Consumption of fermented and nonfermenteddairy products: effects on cholesterol concentrations and metabolism. Am. J. Clin. Nutr. 71: 674-681.

Sridevia, N., Vishweb, P., and A. Prabhunea. 2009. Hypocholesteremic effect of bile salt hydrolasefrom Lactobacillus buchneri ATCC 4005. Food Res. Int. 42:516-520.

Shornikova, A.V., Isolauri, E., Burnakova, L., Lukovnikova, S., and T. Vesikari. 1997b. A trial in theKarelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea. Acta.Paediatr. 86:460-465.

Shornikova, A. V., Casas, I. A., and E. Isolauri. 1997a. Lactobacillus reuteri as a therapeutic agent inacute diarrhea inyoung children. J. Pediatr. Gastroenterol. Nutr. 24:399-404.

Servin, A. L., and M. H. Coconnier. 2003. Adhesion of probiotic strains to the intestinal mucosa andinteraction with pathogens. Best Pract. Res. Clin. Gastroenterol. 17:741-754.

Schultz, M., and R. B. Sartor. 2000. Probiotics and inflammatory bowel diseases. Am. J.Gastroenterol. 95:19S-21S.

Scheinbach, S. 1998. Probiotics: functionality and commercial status. Biotechnol. Adv. 16:581-608.

Sato, M., Uzu, K., Yoshida, T., Hamad, E. M., Kawakami, H., Matsuyama, H., Abd El-Gawad, I. A.,and K. Imaizumi. 2008. Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocytesize in rats. Br. J. Nutr. 99:1013-1017.

Sarkar, S. 2008. Effect of probiotics on biotechnological characteristics of yoghurt: a review. Brit.Food J. 110:717-740.

Santacruz, A., Marcos, A., Warnberg, J., Marti, A., Martin-Matillas, M., Campoy, C., Moreno, L. A.,Veiga, O., Redondo-Figuero, C., Garagorri, J. M., Azcona, C., Delgado, M., Garcia-Fuentes, M.,Collado, M. C., Sanz, Y., and EVASYON Study Group. 2009. Interplay between weight loss and gutmicrobiata composition in overweight adolescents. Obesity (Silver Spring). 17:1906-1915.

Sanders, M. E., and T. R. Klaenhammer. 2001. Invited review: the scientific basis of Lactobacillusacidophilus NCFM functionality as a probiotic. J. Dairy Sci. 84:319-331.

Samuel, B. S., Hansen, E. E., Manchester, J. K., Coutinho, P. M., Henrissat, B., Fulton, R., Latreille,P., Kim, K., Wilson, R. K., and J. I. Gordon. 2007. Genomicand metabolic adaptations ofMethanobrevibacter smithii tothe human gut. Proc. Natl. Acad. Sci. USA. 104:10643-10648.

Salminen, S., von Wright, A., Morelli, L., Marteau, P., Brassart, D., de Vos, W. M., Fonden, R.,Saxelin, M., Collins, K., Mogensen, G., Birkeland, S. E., and T. Mattila-Sandholm. 1998.Demonstration of safety of probiotics: a review. Int. J. Food Microbiol. 44:93-106.

Salminen, S., Isolauri, E., and E. Salminen. 1996. Clinical uses of probiotics for stabilizing the gutmucosal barrier: successful strains and future challenges. Antonie van Leeuwenhoek. 70:347-358.

Saarela, M., Mogensen, G., Fonden, R., Matto, J., and T. Mattila-Sandholm. 2000. Probiotic bacteria:safety, functional and technological properties. J. Biotechnol. 84:197-215.

Russell, S. L., Gold, M. J., Willing, B. P., Thorson, L., McNagny, K. M., and B. B. Finlay. 2013.Perinatal antibiotic treatment affects murine microbiota, immune responses and allergic asthma. GutMicrobes. 4:158-164.

Rogosa, M. 1974. Lactobacillus: Bergey's manual of determinative bacteriology. Williams andWilkins, Baltimore, MA, USA.

Roberfroid, M. B., Bornet, F., Bouley, C., and J. H. Cummings. 1995. Colonic microflora: nutritionand health. Summary andconclusions of an International Life Sciences Institute (ILSI) [Europe]workshop held in Barcelona, Spain. Nutr. Rev. 53:127-130.

Reynier, M. O., Montet, J. C., and A. Gerolami. 1981. Comparative effects of cholic,chenodeoxycholic, and ursodeoxycholic acids on micellar solubilization and intestinal absorption ofcholesterol. J. Lipid Res. 22:467-473.

Reid, G., and J. Burton. 2002. Use of Lactobacillus to prevent infection by pathogenic bacteria.Microbes Infect. 4:319-324.

Reid, G., Sanders, M. E., Gaskins, H. R., Gibson, G. R., Mercenier, A., Rastall, R., Roberfroid, M.,Rowland, I., Cherbut, C., and T. R. Klaenhammer. 2003. New scientific paradigms for probiotics andprebiotics. J. Clin. Gastroenterol. 37:105-118.

Reid, G. 2008. Probiotics and prebiotics-progress and challenges. Int. Dairy J. 18:969-975.

Ray, R. C., and M. Didier. 2015. Microorganisms and fermentation of traditional foods, In: Ray, R. C.,El Sheikh, A. F., and R. S. Kumar., eds., Oriental Fermented Functional (Probiotic) Foods, BocaRaton: CRC Press. pp. 283-311.

Prasad, J., Gill, H., Smart, J., and P. K. Gopal. 1998. Selection and characterization of Lactobacillusand Bifidobacterium strains for use as probiotic. Int. Dairy J. 8:993-1002.

Prado, F. C., Parada, J. L., Pandey, A., and C. R. Soccol. 2008. Trends in non-dairy probiotic107beverages. Food Res. Int. 41:111-123.

Pochapin, M. 2000. The effect of probiotics on Clostridium difficile diarrhea. Am. J. Gastroenterol.95:S11-S13.

Pereira, D. I., and G. R. Gibson. 2002b. Effects of consumption of probiotics and prebiotics on serumlipid levels in humans. Crit. Rev. Biochem. Mol. Biol. 37:259-281.

Pereira, D. I., and G. R. Gibson. 2002a. Cholesterol assimilation by lactic acid bacteria andbifidobacteria isolated from the human gut. Appl. Environ. Microbiol. 68:4689-4693.

Parvez. S., Malik, K. A., Ah Kang, S., and H. Y. Kim. 2006. Probiotics and their fermented foodproducts are beneficial for health. J. Appl. Microbiol. 100:1171-1185.

Parker, R. B. 1974. Probiotics, the other half of the antibiotic story. Anim. Nutr. Health. 29:4-8.

Park, Y. H., Kim, J. G., Shin, Y. W., Kim, S. H., and K. Y. Whang. 2007. Effect of dietary inclusion ofLactobacillus acidophilus ATCC 43121 on cholesterol metabolism in rats. J. Microbiol. Biotechnol.17:655-662.

Park, S. S., Choi, H., Kim, S. J., Kim, O. J., Chae, K. S., and E. S. Kim. 2008. FXR alpha downregulatesLXR alpha signaling at the CETP promoter via a common element. Mol. Cells. 26:409-414.

Park, J. E., Oh, S. H., and Y. S. Cha. 2014. Lactobacillus plantarum LG42 isolated from gajami sikhaedecreases body and fat pad weights in diet-induced obese mice. J. Appl. Microbiol. 116:145-156.

Park, H. S., Lee, S. H., and T. B. Uhm. 1998. Selection of microorganisms for probiotics and theircharacterization. Kor. J. Food Nutr. 27:433-440.

Park, H. J., Park, Y. H., and Y. B. Kim. 2001. Characterization of growth and ethanol formation ofWeissella paramesenteroides P30. Food Sci. Biotechnol. 10:72-75.

Ouwehand, A. C., Salminen, S., and E. Isolauri. 2002. Probiotics: an overview of beneficial effects.Antonie Van Leeuwenhoek. 82:279-289.

Ouwehand, A. C., Kirjavainen, P. V., Shortt, C., and S. Salminen. 1999. Probiotics: mechanisms and106established effects. Int. Dairy J. 9:43-52.

Ouwehand, A. C., Kirjavainen, P. V., Gronlund, M. M., Isolauri, E., and S. J. Salminen. 1999.Adhesion of probiotic micro-organisms to intestinal mucus. Int. J. Food Microbiol. 64:119-126.

Ooi, L. G., and M. T. Liong. 2010. Cholesterol-lowering effects of probiotics and prebiotics: a Reviewof in vivo and in vitro findings. Int. J. Mol. Sci. 11:2499-2522.

Oner, O., Aslim, B., and S. B. Aydas. 2013. Mechanisms of cholesterol-lowering effects of lactobacilliand bifidobacteria strains as potential probiotics with their bsh gene analysis. J. Mol. Microbiol.Biotechnol. 24:12-18.

Okubo, T., Takemura, N., Yoshida, A., and K. Sonoyama. 2013. KK/Ta mice administeredLactobacillus plantarum strain No. 14 have lower adiposity and higher insulin sensitivity. Biosci.Microbiota Food Health. 32:93-100.

Oakey, H. J., Harty, D. W., and K. W. Knox. 1995. Enzyme production by lactobacilli and thepotential link with infective endocarditis. J. Appl. Bacteriol. 78:142-148.

Noh, D. O., Kim, S. H., and S. E. Gilliland. 1997. Incorporation of cholesterol into the celluarmembrane of Lactobacillus acidophilus ATCC 43121. J. Dairy Sci. 80:3107-3113.

Nobaek, S., Johansson, M. L., and G. Molin. 2000. Alteration of intestinal microflora is associatedwith reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am. J.Gastroenterol. 95:1231-1238.

Nilakhe, S., and V. Sapre. 2015. Cholesterol assimilation by intestinal Lactobacilus acidophilus. Res.J. Chem. Environ. 19:10-14.

Nikita, C., and D. Hemangi. 2012. Isolation, identification and characterization of lactic acid bacteriafrom dairy sludge sample. J. Environ. Res. Develop. 7:234-244.

Nielsen, J. W., and S. E. Gilliland. 1992. The lactose hydrolyzing enzyme from Lactobacillusacidophilus. Cult. Dairy Prod. J. 27:20-24.

Nguyen, T. D. T., Kang, J. H., and M. S. Lee. 2007. Characterization of Lactobacillus plantarumPH04, a potential probiotic bacterium with cholesterol-lowering effects. Int. J. Food Microbiol.113:358-361.

Nahaisi, M. H. 1986. Lactobacillus acidophilus: therapeutic properties, products and enumeration, In:Robinson, R. K., ed., Developments in Food Microbiology, London: Elsevier Applied SciencePublishers. pp. 153-178.

Nagpal, R., Yadav, H., Puniya, A. K., Singh, K., Jain, S., and F. Marotta. 2007. Potential of probioticsand prebiotics for symbiotic functional dairy foods. Int. J. Probiotics Prebiotics. 2:75-84.

Nagpal, R., Kumar, A., Kumar, M., Behare, P. V., Jain, S., and H. Yadav. 2012. Probiotics, theirhealth benefits and applications for developing healthier foods: a review. FEMS Microbiol. Lett.334:1-15.

Nadal, I., Santacruz, A., Marcos, A., Warnberg, J., Garagorri, J. M., Moreno, L. A., Martin-Matillas,M., Campoy, C., Marti, A., Moleres, A., Delgado, M., Veiga, O. L., Garcia-Fuentes, M., Redondo, C. G., and Y. Sanz. 2009. Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteriaassociated with weight loss in obese adolescents. Int. J. Obes. 33:758-767.

Mohan, J. C., Arora, R., and M. Khalilullah. 1990. Preliminary observations on effect ofLactobacillus sporogenes on serum lipid levels in hypercholesterolemic patients. Indian. J. Med. Res.92:431-432.

Miyoshi, Y., Okada, S., Uchimura, T., and E. Satoh. 2006. A mucus adhesion promoting protein,MapA, mediates the adhesion of Lactobacillus reuteri to Caco-2 human intestinal epithelial cells.Biosci. Biotechnol. Biochem. 70:1622-1628.

Mital, B. K., and S. K. Garg. 1992. Acidophilus milk products: manufacture and therapeutics. FoodRev. Int. 8:347-389.

Merrell, D. S., and A. Camilli. 2002. Acid tolerance of gastrointestinal pathogens. Curr. Opin.Microbiol. 5:51-55.

Mercenier, A., Pavan, S., and B. Pot. 2002. Probiotics as biotherapeutic agents: Present knowledgeand future prospects. Curr. Pharm. Design 8:99-110.

Mattila-Sandholm, T., Matto, J., and M. Saarela. 1999. Lactic acid bacteria with health claimsinteractionand interference with gastrointestinal flora. Int. Dairy J. 9:25-35.

Martini, M. C., G. L. Bollweg, M. D. Levitt, and D. A. Savaiano. 1987. Lactose digestion by yogurtβ-galactosidase: Influence of pH and microbial cell integrity. Am. J. Clin. Nutr. 45:432-436.

Marteau, P., de Vrese, M., Cellier, C.J., and J. Schrezenmeir.2001. Protection from gastrointestinaldiseases with theuse of probiotics. Am. J. Clin. Nutr. 73:430S-436S.

Marshall, V., and B. Law. 1984. The physiology and growth of dairy lactic-acid Bacteria, In: Davies,F. L., and B. A. Law., eds., Advances in the Microbiology and Biochemistry of Cheese andFermented Milk. London: Elsevier Applied Science Publishers. pp. 67-98.

Marshall, V. M., and W. M. Cole. 1983. Threonine aldolase and alcohol dehydrogenase activities inLactobacillus bulgaricus and Lactobacillus acidophilus and their contribution to flavour production infermented milks. J. Dairy Res. 50:375-379.

Marshall, V. M., Cole, W. M., and L. A. Mabbitt. 1982. Fermentation of specially formulated milkwith single strains of bifidobacteria. J. Soc. Dairy Technol. 35:143-144.

Maragkoudakis, P. A., Zoumpopoulou, G., Miaris, C., Kalantzopoulos, G., Pot, B., and E. Tsakalidou.2006. Probiotic potential of Lactobacillus strains isolated from dairy products. Int. Dairy J. 16:189-199.

Mann, G. V., and A. Spoerry. 1974. Studies of a surfactant and cholesteremia in the Maasai. Am. J.Clin. Nutr. 27:464-469.

Mann, G. V. 1977. A factor in yoghurt which lowers cholesterolemia in man. Arthrosclerosis. 26:335-340.

MacFarlane, G. T., and J. H. Cummings. 2002. Probiotics, infection and immunity. Curr. Opin. Infect.Dis. 15:501-506.

Logan, A. C., and M. Katzman. 2005. Major depressive disorder: probiotics may be an adjuvanttherapy. Med. Hypotheses. 64:533-538.

Ljungh, A., and T. Wadstrom. 2006. Lactic acid bacteria as probiotics. Curr. Issues Intest. Microbiol.7:73-89.

Liong, M. T., and N. P. Shah. 2006. Effects of a Lactobacillus casei synbiotic on serum lipoprotein,intestinal microflora, and organic acids in rats. J. Dairy Sci. 89:1390-1399.

Liong, M. T., and N. P. Shah. 2005. Acid and bile tolerance and cholesterol removal ability oflactobacilli strains. J. Dairy Sci. 88:55-66.

Lin, S. Y., and C. T. Chen. 2000. Reduction of cholesterol by Lactobacillus acidophilus in culturebroth. J. Food Drug Anal. 8:97-102.

Lin, S. Y., Ayres, J. W., Winkler, W., and W. E. Sandine. 1989. Lactobacillus effects on cholesterol:in vitro and in vivo results. J. Dairy Sci. 72:2885-2899.

Lin, M. Y., and T. W. Chen. 2000. Reduction of cholesterol by Lactobacillus acidophilus in culturebroth. J. Food Drug Anal. 8:97-102.

Lim, S. M. 2014. Antimutagenicity activity of the putative probiotic strain Lactobacillus paracaseisubsp. tolerans JG22 isolated from pepper leaves Jangajji. Food Sci. Biotechnol. 23:141-150.

Lim, H. J., Kim, S.Y., and W. K. Lee. 2004. Isolation of cholesterol-lowering lactic acid bacteria fromhuman intestine for probiotic use. J. Vet. Sci. 5:391-395.

Lilly, D. M., and R. H. Stillwell. 1965. Probiotics: Growth-promoting factors produced bymicroorganisms. Science. 147:747-748.

Ley, R. E., Turnbaugh, P. J., Klein, S., and J. I. Gordon. 2006. Microbialecology: human gut microbesassociated with obesity. Nature. 444:1022-1023.

Ley, R. E., Lozupone, C. A., Hamady, M., Knight, R., and J. I. Gordon. 2008. Worlds within worlds:102evolution of the vertebrate gut microbiota. Nat. Rev. Microbiol. 6:776-788.

Ley, R. E., Backhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., and J. I. Gordon. 2005.Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA. 102:11070-11075.

Leroy, F., Falony, G., and L. Vuyst. 2008. Latest developments in probiotics, In: Toldra, F., ed., MeatBiotechnology. Brussels: Springer. Belgium. pp. 217-229.

Lehto, E. M., and S. J. Salminen. 1997. Inhibition of Salmonella typhimurium adhesion to Caco-2 cellcultures by Lactobacillus strain GG spent culture supernate: only a pH effect? FEMS Immunol. Med.Microbiol. 18:125-132.

Lee, M. H., Lu, K., Hazard, S., Yu, H., Shulenin, S., Hidaka, H., Kojima, H., Allikmets, R., Sakuma,N., Pegoraro, R., Srivastava, A. K., Salen, G., Dean, M., and S. B. Patel. 2001. Identification of a gene,ABCG5, important in the regulation of dietary cholesterol absorption. Nat. Genet. 27:79-83.

Lee, H. Y., Park, J. H., Seok, S. H., Baek, M. W., Kim, D. J., Lee, K. E., Paek, K. S., Lee, Y., and J. H.Park. 2006. Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleicacid and show anti-obesity effects in diet-induced obese mice. Biochim. Biophys. Acta. 1761:736-744.

Lee, C. W., Ko, C. Y., and D. M. Ha. 1992. Microfloral changes of the lactic acid bacteria duringkimchi fermentation and identification of the isolates. Kor. J. Appl. Microbiol. Biotechnol. 20:102-109.

Ledesma, O. V., de Ruiz Holgado, A. P., Olivier, G., de Giori, G. S., Raibaud, P., and J. V. Galpin.1977. A synthetic medium for comparative nutritional studies of lactobacilli. J. Appl. Bacteriol.42:123-133.

Kurmann, J. A. 1998. Starters for fermented milks: starters with selected intestinal bacteria. Int. DairyFed. Bull. 227:41-55.

Kumar, R., Grover, S., and V. K. Batish. 2012. Bile salt hydrolase activity screening of lactobacilli invitro selection of indigenous Lactobacillus strains with potential bile salt hydrolysing and cholesterolloweringability. Probiotics Antimicro. Prot. 4:162-172.

Kumar, R., Grover, S., and V. K. Batish. 2011. Hypocholesterolaemic effect of dietary inclusion oftwo putative probiotic bile salt hydrolase-producing Lactobacillus plantarum strains in Sprague-Dawley rats. Br. J. Nutr. 105:561-573.

Kumar, M., Nagpal, R., Kumar, R., Hemalatha, R., Verma, V., Kumar, A., Chakraborty, C., Singh, B.,Marotta, F., Jain, S., and H. Yadav. 2012. Cholesterol-lowering probiotics as potential biotherapeuticsfor metabolic diseases. Exp. Diabetes Res. 2012:902917.

Klein, A., Friedrich, U., Vogelsang, H., and G. Jahreis. 2008. Lactobacillus acidophilus 74-2 andBifidobacterium animalis subsp. lactis DGCC 420 modulate unspecific cellular immune response inhealthy adults. Eur. J. Clin. Nutr. 62:584-593.

Klaver, F. A., and R. van der Meer. 1993. The assumed assimilation of cholesterol by lactobacilli andBifidobacterium bifidum is due to their bile salt-deconjugating activity. Appl. Environ. Microbiol. 59:1120-1124.

Kim, S. J., Cho, S. Y., Kim, S. H., Song, O. J., Shin, I. S., Cha, D. S., and H. J. Park. 2008. Effect ofmicroencapsulation on viability and other characteristics in Lactobacillus acidophilus ATCC 43121. LWT-Food Sci. Technol. 41:493-500.

Kim, S. E., Kim, Y. H., Lee, H. J., Kim, D. O., and H. Y. Kim. 2012. Probiotic properties of lactic acidbacteria isolated from Mukeunji, a long-term ripened kimchi. Food Sci. Biotechnol. 21:1135-1140.

Kim, P. I., Jung, M. Y., Chang, Y. H., Kim, S., Kim, S. J., and Y. H. Park. 2007. Probiotic properties ofLactobacillus and Bifidobacterium strains isolated from porcine gastrointestinal tract. Appl. Microbiol. Biotechnol. 74:1103-1111.

Kaur, I. P., Chopra, K., and A. Saini. 2002. Probiotics: potential pharmaceutical applications. Eur. J.Pharm. Sci. 15:1-9.

Kang, J. H., Yun, S. I., and H. O. Park. 2010. Effects of Lactobacillus gasseri BNR17 on body weightand adipose tissue mass in diet-induced overweight rats. J. Microbiol. 48:712-714.

Kalliomaki, M., Collado, M. C., Salminen, S., and E. Isolauri. 2008. Early differences in fecalmicrobiota composition in children may predict overweight. Am. J. Clin. Nutr. 87:534-538.

Kailasapathy, K., and J. Chin. 2000. Survival and therapeutic potential of probiotic organisms withreference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol. Cell Biol. 78:80-88.

Kailasapathy, K. 2013. Commercial sources of probiotic strains and their validated and potentialhealth benefits: a review. Int. J. Fermented Foods. 2:1-17.

Jones, M. L., Martoni, C. J., Parent, M., and S. Prakash. 2012. Cholesterol-lowering efficacy of amicroencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulationin hypercholesterolaemic adults. Br. J. Nutr. 107:1505-1513.

Jones, M. L., Chen, H., Ouyang, W., Metz, T., and S. Prakash. 2004. Microencapsulated geneticallyengineered Lactobacillus plantarum 80 (pCBH1) for bile acid deconjugation and its implication inlowering cholesterol. J. Biomed. Biotechnol. 2004:61-69.

Jia, Y. J., Xu, R. X., Sun, J., Tang, Y., and J. J. Li. 2014. Enhanced circulating PCSK9 concentrationby berberine through SREBP-2 pathway in high fat diet-fed rats. J. Transl. Med. 12:103.

Jia, L., Betters, J. L., and L. Yu. 2011. Niemann-pick C1-like 1 (NPC1L1) protein in intestinal andhepatic cholesterol transport. Annu. Rev. Physiol. 73:239-259.

Jeun, J. G., Kim, S. Y., Cho, S. Y., Jun, H. J., Park, H. J., Seo, J. G., Chung, M. J., and S. J. Lee. 2010.Hypocholesterolemic effects of Lactobacillus plantarum KCTC 3928 by increased bile acid excretionin C57BL/6 mice. Nutrition. 26:321-330.

James, W. P. 2008. The epidemiology of obesity: the size of the problem. J. Intern. Med. 263:336-352.

Jacobsen, C. N., Roesnfeldt Nielsen, V., Hayford, A. E., Moller, P. L., Michaelsen, K. F., Paerregaard,A., Sandstrom, B., Tvede, M., and M. Jacobsen. 1999. Screening of probiotic activities of forty-sevenstrains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of fiveselected strains in humans. Appl. Environ. Microbiol. 65:4949-4956.

Itoh, T. 1992. Functional benefits from lactic acid bacteria used in cultured milk. Anim. Sci. Technol.(Jpn.) 63:1276-1289.

Hyronimus, B., Le Marrec, C., Sassi, A. H., and A. Deschamps. 2000. Acid and bile tolerance ofspore-forming lactic acid bacteria. Int. J. Food Microbiol. 61:193-197.

Hylemon, P. B., Zhou, H., Pandak, W. M., Ren, S., Gil, G., and P. Dent. 2009. Bile acids as regulatorymolecules. J. Lipid. Res. 50:1509-1520.

Husebye, E., Hellstrom, P. M., Sundler, F., Chen, J., and T. Midtvedt. 2001. Influence of microbialspecies on small intestinal myoelectric activity and transit in germ-free rats. Am. J. Physiol.Gastrointest. Liver Physiol. 280:G368-G380.

Huang, Z., Zhou, X., Nicholson, A. C., Gotto A. M. J., Hajjar, D. P., and J. Han. 2008. Activation ofperoxisome proliferator-activated receptor-α in mice induces expression of the hepatic low-densitylipoprotein receptor. Br. J. Pharmacol. 155:596-605.

Huang, Y., Wang, J., Cheng, Y., and Y. Zheng. 2010. The hypocholesterolaemic effects ofLactobacillus acidophilus American type culture collection 4356 in rats are mediated by the downregulationof Niemann-Pick C1-like 1. Br. J. Nutr. 104:807-812.

Hood, S. K., and M. L. Zottola. 1988. Effect of low pH on the ability of Lactobacillus acidophilus tosurvive and adhere to human intestinal cell. J. Food Sci. 53:1514-1516.

Hong, H. J., Kim, E. G., Cho, D. H., and T. S. Kim. 2010. Differential suppression of heat-killedlactobacilli isolated from kimchi, a Korean traditional food, on airway hyper-responsiveness in mice. J.Clin. Immunol. 30:449-458.

Holzapfel, W. H., Haberer, P., Geisen, R., Bjorkroth, J., and U. Schillinger. 2001. Taxonomy andimportant features of probiotic microorganisms in food and nutrition. Am. J. Clin. Nutr. 73:365S-373S.

Hofmann, A. F. 1994. Bile acids, In: Arias, I. M., Boyer, J. L., Fausto, N., Jackoby, W. B., Schachter,D. A., and D. A. Shafritz. eds., the liver: Biology and Pathobiology, New York, NY: Raven Press.USA. pp. 677-718.

Harrison, V. C., and G. Peat. 1975. Serum cholesterol and bowel flora in the newborn. Am. J. Clin.Nutr. 28:1351-1355.

Hammes, W. P., and R. F. Vogel. 1995. The Genus Lactobacillus, In: Wood, B. J. B., Holzapfel, W.H., eds., The genera of lactic acid bacteria, London: Blackie Academic. pp. 19-54.

Hamad, E. M., Sato, M., Uzu, K., Yoshida, T., Higashi, S., Kawakami, H., Kadooka, Y., Matsuyama,H., Abd El-Gawad, I. A., and K. Imaizumi. 2009. Milk fermented by Lactobacillus gasseri SBT2055influences adipocyte size via inhibition of dietary fat absorption in Zucker rats. Br. J. Nutr. 101:716-724.

Gyllenberg, H., Rossander, M., and P. Roine. 1956. Effect of the fatty acids of human milk and cow'smilk on intestinal lactobacilli. Acta Paediatr. 45:147-160.

Guarner, F., and J. R. Malagelada. 2003. Gut flora in health and disease. Lancet. 361:512-519.

Grunewald, K. K. 1982. Serum cholesterol levels in rats fed skim milk fermented by Lactobacillusacidophilus. J. Food Sci. 47:2078-2079.

Gorbach, S. L., Chang, T.W., and B. Goldin. 1987. Successful treatment of relapsing Clostridiumdifficile colitis with Lactobacillus GG. Lancet. 2:1519 (letter).

Gorbach, S. L. 2002. Probiotics in the third millennium. Dig. Liver Dis. 34:S2-S7.

Gomes, A. M. P., and F. X. Malcata. 1999. Bifidobacterium ssp. and Lactobacillus acidophilus:biological, biochemical, technological and therapeutical properties relevant for use as probiotics.Trends in Food Sci. Technol. 10:139-157.

Goldin, B. R., and S. L. Gorbach. 1992. Probiotics for humans, In: Fuller, R., ed., Probiotics thescientific basis, London: Chapman and Hall. pp. 355-376.

Gismondo, M. R., Drago, L., and A. Lombardi. 1999. Review of probiotics available to modifygastrointestinal flora. Int. J. Antimicrob. Agents. 12:287-292.

Gilliland, S. E., Nelson, C. R., and C. Maxwell. 1985. Assimilation of cholesterol by Lactobacillusacidophilus. Appl. Environ. Microbiol. 49:377-381.

Gilliland, F. D., Mahler, R., Hunt, W. C., and S. M. Davis. 1999. Preventive health care among ruralAmerican Indians in New Mexico. Prev. Med. 28:194-202.

Gill, S. R., Pop, M., Deboy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I.,Relman, D. A., Fraser-Liggett, C. M., and K. E. Nelson. 2006. Metagenomic analysis of the humandistal gut microbiome. Science. 312:1355-1359.

Fuller, R. 1989. Probiotics in man and animals. J. Appl. Bacteriol. 66:365-378.

Food and Agriculture Organization of the United Nations and World Health Organization(FAO/WHO). 2001, posting date. Regulatory and clinical aspects of dairy probiotics. Food andAgriculture Organization of the United Nations and World Health Organization Expert ConsultationReport. Food and Agriculture Organization of the United Nations and World Health OrganizationWorking Group Report. (Online).

Fernandez, M. F., Boris, S., and C. Barbes. 2003. Probiotic properties of human lactobacilli strains tobe used in the gastrointestinal tract. J. Appl. Microbiol. 94:449-455.

Feighner, S. D., and M. P. Dashkevicz. 1988. Effect of dietary carbohydrates on bacterialcholyltaurine hydrolase in poultry intestinal homogenates. Appl. Environ. Microbiol. 54:337-342.

Duval, C., Touche, V., Tailleux, A., Fruchart, J. C., Fievet, C., Clavey, V., Staels, B., and S. Lestavel.2006. Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine.Biochem. Biophys. Res. Commun. 340:1259-1263.

Dunne, C., O?Mahony, L., Murphy, L., Thornton, G., Morrissey, D., O?Halloran, S., Feeney, M.,Flynn, S., Fitzgerald, G., Daly, C., Kiely, B., O?Sullivan, G. C., Shanahan, F., and J. K. Collins. 2001. In vitro selection criteria for probiotic bacteria of human origin: Correlation with in vivo findings. Am. J. Clin. Nutr. 73:386S-392S.

Desmazeaud, M. 1983. Nutrition of lactic acid bacteria: state of the art. Le lait. 63:267-316.

De Smet, I., van Hoorde, L., De Saeyer, N., Vande Woestyne, M., and W. Verstraete. 1994. In vitrostudy of bile salt hydrolase (BSH) activity of BSH isogenic Lactobacillus plantarum 80 strains andestimation of cholesterol lowering through enhanced BSH activity. Microb. Ecol. Health Dis. 7:315-329.

De Rodas, B. Z., Gilliland, S. E., and C. V. Maxwell. 1996. Hypocholesterolemic action ofLactobacillus acidophilus ATCC 43121 and calcium in swine with hypercholesterolemia induced bydiet. J. Dairy Sci. 79:2121-2128.

Daniel, H., Moghaddas Gholami, A., Berry, D., Desmarchelier, C., Hahne, H., Loh, G., Mondot, S.,Lepage, P., Rothballer, M., Walker, A., Bohm, C., Wenning, M., Wagner, M., Blaut, M., Schmitt-Kopplin, P., Kuster, B., Haller, D., and T. Clavel. 2014. High-fat diet alters gut microbiota physiologyin mice. ISME J. 8:295-308.

Conly, J. M., Stein, K., Worobetz, L., and S. Rutledge-Harding. 1994. The contribution of vitamin K2(metaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K.Am. J. Gastroenterol. 89:915-923.

Coconnier, M. H., Klaenhammer, T. R., Kerneis, S., Bernet, M. F., and A. L. Servin. 1992. Proteinmediatedadhesion of Lactobacillus acidophilus BG2FO4 on human enterocyte and mucus-secretingcell lines in culture. Appl. Environ. Microbiol. 58:2034-2039.

Chou, L. S., and B. Weimer. 1999. Isolation and characterization of acid- and bile-tolerant isolatesfrom strains of Lactobacillus acidophilus. J. Dairy Sci. 82:23-31.

Chomarat, M., and D. Espinouse. 1991. Lactobacillus rhamnosus septicemia in patients withprolonged aplasia receiving ceftazidime-vancomycin. Eur. J. Clin. Microbiol. Infect. Dis. 10:44.

Chiu, C. H., Lu, T. Y., Tseng, Y. Y., and T. M. Pan. 2006. The effects of Lactobacillus-fermented milkon lipid metabolism in hamsters fed on high-cholesterol diet. Appl. Microbiol. Biotechnol. 71:238-245.

Chikai, T., Nakao, H., and K. Uchida. 1987. Deconjugation of bile acids by human intestinal bacteriaimplanted in germ-free rats. Lipids. 22:669-671.

Cheigh, H. S., and K. Y. Park. 1994. Biochemical, microbiological, and nutritional aspects of kimchi.(Koraen fermented vegetable products). Crit. Rev. in Food Sci. Nutr. 34:175-203.

Charteris, W. P., Kelly, P. M., Morelli, L., and J. K. Collins. 1998. Development and application of anin vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus andBifidobacterium species in the upper human gastrointestinal tract. J. Appl. Microbiol. 84:759-768.

Charteris, W. P., Kelly, P. M., Morelli, L., and J. K. Collins. 1998. Antibiotic susceptibility ofpotentially probiotic Bifidobacterium isolates from the human gastrointestinal tract. Lett. Appl.Microbiol. 26:333-337.

Chan, E. S., and Z. Zhang. 2005. Bioencapsulation by compression coating of probiotic bacteria fortheir protection in an acidic medium. Process Biochem. 40:3346-3351.

Carey, M. C., and W. C. Duane. 1994. Enterohepatic circulation, In: Arias, I. M., Boyer, N., Fausto, N.,Jackoby, W. B., Schachter, D. A., and D. A. Shafritz, eds., the liver: Biology and Pathobiology, NewYork, NY: Raven Press. USA. pp. 719-738.

Caplan, M. S., and T. Jilling. 2000. Neonatal necrotizing enterocolitis: possible role of probioticsupplementation. J. Pediatr. Gastroenterol. Nutr. 30:S18-S22.

Cani, P. D., Neyrinck, A. M., Fava, F., Knauf, C., Burcelin, R. G., Tuohy, K. M., Gibson, G. R., andN. M. Delzenne. 2007. Selective increases of bifidobacteria in gut microflora improve high fat-dietinduceddiabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 50:2374-2383.

Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F.,Tuohy, K. M., Chabo, C., Waget, A., Delmee, E., Cousin, B., Sulpice, T., Chamontin, B., Ferrieres, J.,Tanti, J. F., Gibson, G. R., Casteilla, L., Delzenne, N. M., Alessi, M. C., and R. Burcelin. 2007. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 56:1761-1772.

Cammarota, M., De Rosa, M., Stellavato, A., Lamberti, M., Marzaioli, I., and M. Giuliano. 2009. Invitro valuation of Lactobacillus plantarum DSMZ 12028 as a probiotic: emphasis on innate immunity.Int. J. Food Microbiol. 135:90-98.

Buck, L. M., and S. E. Gilliland. 1994. Comparison of freshly isolated strains of Lactobacillusacidophilus of human intestinal origin for ability to assimilate cholesterol during growth. J. Dairy Sci.77:2925-2933.

Brashears, M. M., Gilliland, S. E., and L. M. Buck. 1998. Bile salt deconjugation and cholesterolremoval from media by Lactobacillus casei. J. Dairy Sci. 81:2103-2110.

Berge, K. E., Tian, H., Graf, G. A., Yu, L., Grishin, N. V., Schultz, J., Kwiterovich, P., Shan, B.,Barnes, R., and H. H. Hobbs. 2000. Accumulation of dietary cholesterol in sitosterolemia caused bymutations in adjacent ABC transporters. Science. 290:1771-1775.

Bengmark, S. 2000. Colonic food: pre- and probiotics. Am. J. Gastroenterol. 95:S5-S7.

Banasaz, M., Norin, E., Holma, R., and T. Midtvedt. 2002. Increased enterocyte production ingnotobiotic rats mono-associated with Lactobacillus rhamnosus GG. Appl. Environ. Microb.68:3031-3034.

Ballantyne, C. M. 1998. Current thinking in lipid lowering. Am. J. Med. 104:33S-41S.

Babu, V., Mital, B. K., and S. K. Garg. 1992. Effect of tomato juice addition on the growth andactivity of Lactobacillus acidophilus. Int. J. Food Microbiol. 17:67-70.

Ashar, M. N., and J. B. Prajapati. 2001. Role of probiotic culturesand fermented milks in combatingblood cholesterol. Indian J. Microbiol. 41:75-86.

Anandharaj, M., Sivasankari, B., and R. P. Rani. 2014. Effects of probiotics, prebiotics, and synbioticson hypercholesterolemia: a review. Chinese J. Biol. 1-7.

Amara, A. A., and A. Shibl. 2013. Role of probiotics in health improvement, infection control anddisease treatment and management. Saudi Pharm. J. 23:107-14.

Alo?lu, H., and Z. Oner. 2006. Assimilation of cholesterol in broth, cream, and butter by probioticbacteria. Eur. J. Lipid Sci. Technol. 108:709-713.

Aiba, Y., Suzuki, N., Kabir, A. M., Takagi, A., and Y. Koga. 1998. Lactic acid-mediated suppressionof Helicobacter pylori by the oral administration of Lactobacillus salivariusas a probiotic in agnotobiotic murine model. Am. J. Gastroenterol. 93:2097-2101.

Abd El-Gawad, I. A., El-Sayed, E. M., Hafez, S. A., El-Zeini, H. M., and F. A. Saleh. 2005. Thehypocholesterolaemic effect of milk yoghurt and soy-yoghurt containing bifidobacteria in rats fed ona cholesterol-enriched diet. Inter. Dairy J. 15:37-44.

김치에서 분리한 새로운 프로바이오틱스의 개발을 위한 Lactobacillus species의 스크리닝 및 평가 : Screening and evaluation of Lactobacillus species for the development of novel probiotics isolated from kimchi

유사주제 논문( 844)

' 김치에서 분리한 새로운 프로바이오틱스의 개발을 위한 Lactobacillus species의 스크리닝 및 평가 : Screening and evaluation of Lactobacillus species for the development of novel probiotics isolated from kimchi' 의 주제별 논문영향력

주제별 논문영향력

' 김치에서 분리한 새로운 프로바이오틱스의 개발을 위한 Lactobacillus species의 스크리닝 및 평가 : Screening and evaluation of Lactobacillus species for the development of novel probiotics isolated from kimchi' 의 참고문헌

' 김치에서 분리한 새로운 프로바이오틱스의 개발을 위한 Lactobacillus species의 스크리닝 및 평가 : Screening and evaluation of Lactobacillus species for the development of novel probiotics isolated from kimchi' 의 유사주제( ) 논문